About this trial
Large blood sugar and insulin increases after meals high in table sugar are related to risk for diabetes and heart disease. Additionally, large increases in blood sugar may also negatively impact vascular health. Previous research suggests that mango consumed in small quantities has blood sugar-lowering properties, but the evidence of this within larger, more realistic meals is limited. The investigators want to understand if replacing table sugar (sucrose) with sugar from fresh mango (which also contains fiber and plant bioactives) will lead to more favorable blood sugar, insulin, and vascular responses after eating breakfast meals. The investigators will compare the postprandial glycemic, insulinemic, and vascular response to low and high glycemic meals sweetened with either fresh mango or sucrose.
Eligibility criteria
Qualifiers
18 - 45 years.
Body mass index between 18.5-35.0 kg/m2
Not pregnant (females only)
Not postmenopausal (females only).
Disqualifiers
Not between the ages of 18-45
Body mass index < 18.5 kg/m2 or >35.0 kg/m2
Pregnant (females only)
Postmenopausal status (females only).
Trial design
Treatments tested in this trial
- Low-Glycemic Breakfast Containing Oats and Mango
- High-Glycemic Breakfast Containing Cereal and Mango
- Low-Glycemic Breakfast Containing Oats and Table Sugar
- High-Glycemic Breakfast Containing Cereal and Table Sugar
Treatment groups
Sponsors and collaborators
Ball State University
Lead sponsor
National Mango Board
Collaborator